Preoperative Prehabilitation for Sarcopenic Patients Prior to Pancreatic Surgery for Cancer
Key facts
- Who runs it
- University Hospital, Lille
- Where
- France1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Terminated
- People taking part
- 6 people enrolled
- Started
- 17 May 2022
- Ended
- 17 Jun 2025
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Prehabilitation program
- Oral Impact
- Record updated
- 14 July 2026
- Why it stopped
- The study was terminated prematurely due to patient inclusion difficulties.
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (6)Hide the full registry criteria
Who can take part
- Patients undergoing pancreaticoduodenectomy for cancer
- Sarcopenic status
Who cannot take part
- Emergent surgery
- Medical contraindications including cardiovascular disease or clinically significant vascular disease
- Age younger than 18 years
- Physical inability to exercise
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Major digestive surgery is associated with a significant rate of postoperative complications. To improve postoperative outcome, efforts are focused on postoperative course leading to the concept of rehabilitation. However, the rehabilitation concept does not allow to improve muscular and functional reserves at the time of surgery. Sarcopenia is a condition characterized by loss of skeletal muscle mass and function. Also, the prevalence of sarcopenia in patients with cancer is high and has a prevalence of around 25% in patients with pancreatic cancer, with a considerable impact on postoperative and survival outcomes.
Read full original descriptionShow less
The hypothesis is the preoperative management of sarcopenia by a rehabilitation program could improve patients' operative outcomes by reducing the rate of postoperative complications.
The 2 groups in the trial
- PREHABTreatment being tested
Treatment: Prehabilitation program
- control groupExisting treatment, for comparison
Treatment: Oral Impact
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Prehabilitaion Program for Sarcopenic Patients Prior to Pancreaticoduodenectomy for Periampullary Malignant Tumors
- Record updated
- 14 July 2026